the truth about bpc 157 Peptides, Compounding Pharmacies, and FDA Regulation BPC-157: The Peptide That's Changing

Methylation has never tasted so good

Los Angeles, California--(Newsfile Corp

argenx advances clinical development of efgartigimod in orimary Sjogrens disease [press release]

Need Help with CPT Coding

The Center for Medicare and Medicaid Innovation (CMMI) recently announced a voluntary, 10-year Medicare payment and service delivery model: Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model

2.4 Administration of NASCOBAL with Other Therapy NASCOBAL should be administered with other therapy(ies) in: Patients with concurrent folate and vitamin B12 deficiency:Administer folic acid in addition to NASCOBAL Patients with concurrent iron and vitamin B12 deficiency:Administer iron in addition to NASCOBAL Patients with correctible causes of vitamin B12 deficiency:Consider measures to treat the underlying condition associated with vitamin B12 deficiency in addition to treatment with NASCOBAL 3